AETERNA ZENTARIS

What this means for you

This application is over — abandoned 02 Nov 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

78437128

Mark type

Stylized text

Filed

17 Jun 2004

Abandoned

02 Nov 2017

Attorney of record

Mark I. Peroff

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of hematological diseases, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparations used for the treatment of ophtalmological disorders, pharmaceutical preparations used for the treatment of reproductive system disorders, pharmaceutical preparations used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparations used for the treatment of benign prostatic hyperplasia (BPH), pharmaceutical preparations used for the treatment of tropical diseases, pharmaceutical preparations used for the treatment of infectious disease, pharmaceutical preparations used for the treatment of leishmaniasis, pharmaceutical preparations used for the treatment of obesity, pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes, pharmaceutical preparations containing conjugated and non-conjugated cytotoxic products used to selectively and specifically target certain types of cancer; pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform used for the treatment of certain types of cancer and endocrine disorders, pharmaceutical preparations based on bombesin antagonist platform used for the treatment of certain types of cancer, pharmaceutical preparations based on inhibitors of the Akt pathway used for the treatment of certain types of cancer, pharmaceutical preparations based on angiogenesis inhibitors platform with multiple mechanisms of action used for the treatment of certain types of cancer, pharmaceutical preparations used to induce apoptosis, pharmaceutical preparations used to stimulate growth hormone secretagogue (GHS)

Owner

• Aeterna Zentaris Inc., Quebec, CA

Prosecution history

• 27 Nov 2017 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
• 27 Nov 2017 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 01 Jun 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 01 May 2017 — INQUIRY AS TO SUSPENSION MAILED
• 01 May 2017 — SUSPENSION INQUIRY WRITTEN
• 01 Nov 2016 — LETTER OF SUSPENSION MAILED
• 01 Nov 2016 — SUSPENSION LETTER WRITTEN
• 31 Oct 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 31 Oct 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 24 Oct 2016 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
• 01 Sept 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 01 Sept 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 17 May 2016 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
• 17 May 2016 — INQUIRY TO SUSPENSION E-MAILED
• 17 May 2016 — SUSPENSION INQUIRY WRITTEN